Developer docs
API playgroundTry for free, no card

Search company profiles

Winona

Full company profile

uuid0002b8g

Namestring
Winona
Legal namestring
Winona
Websiteurl
bywinona.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Winona is a physician-led, direct-to-consumer telehealth company that prescribes and delivers custom-compounded bioidentical hormone replacement therapy (HRT) to women experiencing perimenopause and menopause symptoms. The platform pairs a self-service health quiz and free initial medical visit with consultations by board-certified physicians who prescribe symptom-based — rather than blood- or saliva-test-based — HRT in four delivery variants: body cream, vaginal, oral, and patch formulations. The company is headquartered in Austin, Texas, operates with 11–50 employees, and is VC-backed. The platform is anchored by a proprietary telehealth workflow and a 100,000+ patient intake assessment dataset that underpins both clinical decision-making and the State of Menopause 2026 research report.

The company serves a primary consumer segment of perimenopausal and menopausal women aged 35+ reporting an average of nine concurrent symptoms, plus an emerging corporate wellness B2B channel. Distribution is exclusively DTC through bywinona.com, with a self-serve PLG onboarding flow, free unlimited physician follow-ups, free shipping, and pause-or-cancel-anytime flexibility. Service is available in 33 U.S. states and Puerto Rico. Marketing is multi-channel — SEO content covering 100+ symptoms, a free symptom quiz, an email newsletter, paid social/retargeting, live Q&A webinars, earned media in Elle, People, Harper's Bazaar, and the Los Angeles Times, and a 4.6 Trustpilot rating across 7,180+ reviews.

Revenue is generated primarily through recurring monthly HRT subscriptions priced at approximately $120–$300 per month depending on services and treatment type. Payment is out-of-pocket, with HSA/FSA supported at checkout and some private/employer-designated insurance plans accepted on a reimbursement or plan-dependent basis. A Corporate Wellness offering and an Affiliate Program provide additional B2B and partner-driven revenue streams. Founders Austin Kueffner, Konrad Billetz, and Robert Schmidt lead the company, with Joel Green as CTO and Mike Green as CMO; no parent company, incorporation jurisdiction, or cap-table details are disclosed.

Short descriptiontext

Winona is a physician-led, direct-to-consumer telehealth company that prescribes and delivers custom-compounded bioidentical hormone replacement therapy to perimenopausal and menopausal women aged 35+ in 33 U.S. states and Puerto Rico, generating revenue from recurring monthly subscriptions of approximately $120–$300 per month.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
bioidentical hormone therapy, menopause telehealth services, compounded HRT medications, women's midlife health, perimenopause treatment
Industry3 codes
PRIMARYHLALAHAB
Contraception & Family Planning Telehealth (birth control, counseling, follow-up)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLALACAI
Virtual PT/OT/MSK & Rehab Programs (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALACAL
Population Health Outreach, Preventive Care & Screening Virtual Programs (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
NAICS code2 codes
  • Home Health Care Services62161
  • Home Health Care Services621610
SIC code2 codes
  • Services-Health Services8000
  • Services-Home Health Care Services8082
Product category
Menopause Telehealth
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Direct-to-Consumer Telehealth HRT Subscriptions
TypeSubscription Recurring
Description

Recurring revenue from online telehealth consultations paired with ongoing shipments of prescribed bioidentical hormone medications (pills, creams, patches, vaginal preparations) shipped directly to the patient's home. Per third-party guides, online HRT pricing for platforms in this category ranges from approximately $120 to $300 per month depending on services and treatment type.

policylab.us
2Out-of-Pocket and HSA/FSA Medication Sales
TypeHardware Sales
Description

Patients can pay out-of-pocket and submit receipts to insurance for possible reimbursement, or use HSA (Health Saving Account) and FSA (Flexible Spending Account) funds to pay for Winona prescriptions at checkout, providing an alternative payment channel.

bywinona.com
3Corporate Wellness Partnerships
TypeManaged Services
Description

Winona offers a Corporate Wellness program (referenced via bywinona.com/case-study/corporate-wellness) and has signaled plans to expand partnerships across telehealth, pharmaceutical, and wellness sectors, indicating B2B partnership revenue potential.

finance.yahoo.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details3 tiers
1Online HRT subscription, approximately $120 to $300 per month depending on services and treatment type
ModelSubscriptionBilling cadenceMonthly
Notes

Third-party consumer guide (policylab) places Winona in a range of approximately $120 to $300 per month for online HRT, varying by treatment type, services included, and clinical oversight. The 2026 guide notes the FDA updated labeling for several menopausal hormone therapy products in 2026.

policylab.us
2Pay out-of-pocket or via HSA/FSA; insurance reimbursement supported
ModelOtherBilling cadenceMonthly
Notes

Some private or employer-designated insurance providers may pay for Winona depending on plan and deductible. Patients can opt to pay out-of-pocket and submit receipts to insurance for possible reimbursement. HSA and FSA can be used to pay for Winona prescriptions at checkout.

bywinona.com
3Includes free shipping, free unlimited follow-ups, and free initial medical visit
ModelSubscriptionBilling cadenceMonthly
Notes

Winona's site emphasizes free shipping, free unlimited follow-up care, a free medical intake/visit, and pause-or-cancel-anytime flexibility. Lab testing is not required and is generally not the basis for prescribing.

policylab.us
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Winona is a direct-to-consumer telehealth company that prescribes and delivers personalized, compounded bioidentical hormone replacement therapy (HRT) for perimenopausal and menopausal women. Treatments include body cream, vaginal, oral, and patch formulations prescribed by board-certified physicians based on symptom severity rather than blood or saliva hormone testing, and shipped directly to patients' homes. The service bundles a free online medical intake, free unlimited physician follow-ups, and pause-or-cancel-anytime flexibility, available in 33 U.S. states and Puerto Rico.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 75% of women report six or more concurrent menopause symptoms
+7 more records
Product overview1 text field

Winona operates as a single unified service: a physician-led telehealth platform dedicated to perimenopause and menopause care. The core offering, the Winona Menopause Care Telehealth Service, wraps around its central treatment, Winona Bioidentical Hormone Replacement Therapy (HRT), which is delivered in four formulation variants — Winona Body Cream HRT, Winona Vaginal HRT, Winona Oral HRT, and Winona Patch HRT. Patients access care through the Winona Patient Portal (app.bywinona.com), onboard via the Winona Health Quiz, and continue learning through the Winona Live Q&A sessions and the Winona Menopause Journal content library. The platform is complemented by the Winona Research Initiative, a research program announced in 2026, and a community layer, The Winona Women Facebook Community. Together these modules form a vertically integrated menopause care experience — from assessment and physician consultation, to compounded prescription and home delivery, to ongoing education and research.

Product and service2 records
1Winona Bioidentical Hormone Replacement Therapy (HRT)
2Winona Menopause Care Telehealth Service
CategoryTelehealth Service
Description

Physician-led telehealth service that empowers, educates, and treats women throughout perimenopause and menopause, bundling a free online medical intake / symptom quiz, free unlimited physician follow-ups via the patient portal, ongoing therapy adjustment, and prescribed compounded bioidentical HRT shipped directly to the patient's home. The service is available in 33 U.S. states and Puerto Rico and can be paused or canceled anytime.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Midi Health is a venture-backed telehealth clinic focused on perimenopause and menopause care for women 35+, offering clinician-prescribed HRT and lifestyle interventions. Direct overlap with Winona on target customer (midlife women), care model (telehealth + prescription), and treatment category (HRT).

TypeDirect peer
Description

Evernow is a telehealth provider offering virtual menopause care with prescriptions for HRT and non-hormonal treatments delivered to patients' homes. Closely comparable to Winona in patient profile, telehealth-first delivery, and HRT-led treatment model.

TypeDirect peer
Description

Elektra Health is a digital menopause care platform combining telehealth clinicians with education and community programming for women in midlife. Comparable to Winona on patient segment and virtual care delivery, with overlapping emphasis on education and community alongside clinical care.

TypeDirect peer
Description

Alloy is a telehealth platform serving women 40+ with menopause and perimenopause treatment including compounded bioidentical HRT. Direct peer to Winona in compounded HRT prescribing, cash-pay subscription model, and perimenopause/menopause positioning.

TypeDirect peer
Description

Gennev is a women's health platform focused on menopause care, offering telehealth visits with menopause-certified providers and prescription treatments. Comparable to Winona on patient demographic (women in menopause), virtual care delivery, and treatment-led approach.

TypeDirect peer
Description

Bonafide is a women's health company offering non-prescription and clinician-recommended products for menopause symptoms, with a growing telehealth and prescription offering. Adjacent to Winona in menopause symptom treatment, with overlap in audience and DTC women's health positioning.

TypeBroad incumbent
Description

Hims & Hers is a large-scale telehealth and DTC wellness platform offering prescriptions across multiple categories including women's health and hormone-related treatments. Broader incumbent that competes for the same telehealth-HRT consumer wallet but operates across many conditions beyond menopause.

8Ro (Roman)
TypeBroad incumbent
Description

Ro is a multi-condition telehealth and pharmacy platform offering at-home diagnostics, prescriptions, and ongoing care, with categories overlapping women's health. Comparable as a broad incumbent in DTC telehealth but not specialized in menopause.

TypeEmerging player
Description

Maven Clinic is a virtual care platform focused on women's and family health, including fertility, pregnancy, postpartum, and increasingly perimenopause/menopause. Overlaps with Winona on women's virtual care audience and employer channel, but is broader across the life stages.

10Tia
TypeEmerging player
Description

Tia operates hybrid in-person and virtual women's health clinics covering primary care, gynecology, and perimenopause/menopause care. Comparable to Winona on women-focused care and menopause, though Tia differentiates via physical clinics and a different cost structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Winona

Menopause Telehealthbywinona.com

Winona is a physician-led, direct-to-consumer telehealth company that prescribes and delivers custom-compounded bioidentical hormone replacement therapy to perimenopausal and menopausal women aged 35+ in 33 U.S. states and Puerto Rico, generating revenue from recurring monthly subscriptions of approximately $120–$300 per month.

What Winona does

Winona is a physician-led, direct-to-consumer telehealth company that prescribes and delivers custom-compounded bioidentical hormone replacement therapy (HRT) to women experiencing perimenopause and menopause symptoms. The platform pairs a self-service health quiz and free initial medical visit with consultations by board-certified physicians who prescribe symptom-based — rather than blood- or saliva-test-based — HRT in four delivery variants: body cream, vaginal, oral, and patch formulations. The company is headquartered in Austin, Texas, operates with 11–50 employees, and is VC-backed. The platform is anchored by a proprietary telehealth workflow and a 100,000+ patient intake assessment dataset that underpins both clinical decision-making and the State of Menopause 2026 research report.

The company serves a primary consumer segment of perimenopausal and menopausal women aged 35+ reporting an average of nine concurrent symptoms, plus an emerging corporate wellness B2B channel. Distribution is exclusively DTC through bywinona.com, with a self-serve PLG onboarding flow, free unlimited physician follow-ups, free shipping, and pause-or-cancel-anytime flexibility. Service is available in 33 U.S. states and Puerto Rico. Marketing is multi-channel — SEO content covering 100+ symptoms, a free symptom quiz, an email newsletter, paid social/retargeting, live Q&A webinars, earned media in Elle, People, Harper's Bazaar, and the Los Angeles Times, and a 4.6 Trustpilot rating across 7,180+ reviews.

Revenue is generated primarily through recurring monthly HRT subscriptions priced at approximately $120–$300 per month depending on services and treatment type. Payment is out-of-pocket, with HSA/FSA supported at checkout and some private/employer-designated insurance plans accepted on a reimbursement or plan-dependent basis. A Corporate Wellness offering and an Affiliate Program provide additional B2B and partner-driven revenue streams. Founders Austin Kueffner, Konrad Billetz, and Robert Schmidt lead the company, with Joel Green as CTO and Mike Green as CMO; no parent company, incorporation jurisdiction, or cap-table details are disclosed.

Winona firmographics

Firmographics
Name
Winona
Legal name
Winona
Website
https://bywinona.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
Winona is a physician-led, direct-to-consumer telehealth company that prescribes and delivers custom-compounded bioidentical hormone replacement therapy to perimenopausal and menopausal women aged 35+ in 33 U.S. states and Puerto Rico, generating revenue from recurring monthly subscriptions of approximately $120–$300 per month.
Ownership category
akta.pro rank

Winona industry classification

Industry
Product category
Menopause Telehealth
NAICS
Home Health Care Services (62161), Home Health Care Services (621610)
SIC
Services-Health Services (8000), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLALAHAB
Contraception & Family Planning Telehealth (birth control, counseling, follow-up)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLALACAI
Virtual PT/OT/MSK & Rehab Programs (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALACAL
Population Health Outreach, Preventive Care & Screening Virtual Programs (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms

Keywords

  • Bioidentical hormone therapy
  • Menopause telehealth services
  • Compounded HRT medications
  • Women's midlife health
  • Perimenopause treatment

Where Winona is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

Winona business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Direct-to-Consumer Telehealth HRT Subscriptions: Recurring revenue from online telehealth consultations paired with ongoing shipments of prescribed bioidentical hormone medications (pills, creams, patches, vaginal preparations) shipped directly to the patient's home. Per third-party guides, online HRT pricing for platforms in this category ranges from approximately $120 to $300 per month depending on services and treatment type.
  2. Out-of-Pocket and HSA/FSA Medication Sales: Patients can pay out-of-pocket and submit receipts to insurance for possible reimbursement, or use HSA (Health Saving Account) and FSA (Flexible Spending Account) funds to pay for Winona prescriptions at checkout, providing an alternative payment channel.
  3. Corporate Wellness Partnerships: Winona offers a Corporate Wellness program (referenced via bywinona.com/case-study/corporate-wellness) and has signaled plans to expand partnerships across telehealth, pharmaceutical, and wellness sectors, indicating B2B partnership revenue potential.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyOnline HRT subscription, approximately $120 to $300 per month depending on services and treatment type
OtherMonthlyPay out-of-pocket or via HSA/FSA; insurance reimbursement supported
SubscriptionMonthlyIncludes free shipping, free unlimited follow-ups, and free initial medical visit

Go-to-market motion4 records

Distribution channels3 records

Marketing channels11 records

Winona product offering

Product offering

Core offering

Winona is a direct-to-consumer telehealth company that prescribes and delivers personalized, compounded bioidentical hormone replacement therapy (HRT) for perimenopausal and menopausal women. Treatments include body cream, vaginal, oral, and patch formulations prescribed by board-certified physicians based on symptom severity rather than blood or saliva hormone testing, and shipped directly to patients' homes. The service bundles a free online medical intake, free unlimited physician follow-ups, and pause-or-cancel-anytime flexibility, available in 33 U.S. states and Puerto Rico.

Product overview

Winona operates as a single unified service: a physician-led telehealth platform dedicated to perimenopause and menopause care. The core offering, the Winona Menopause Care Telehealth Service, wraps around its central treatment, Winona Bioidentical Hormone Replacement Therapy (HRT), which is delivered in four formulation variants — Winona Body Cream HRT, Winona Vaginal HRT, Winona Oral HRT, and Winona Patch HRT. Patients access care through the Winona Patient Portal (app.bywinona.com), onboard via the Winona Health Quiz, and continue learning through the Winona Live Q&A sessions and the Winona Menopause Journal content library. The platform is complemented by the Winona Research Initiative, a research program announced in 2026, and a community layer, The Winona Women Facebook Community. Together these modules form a vertically integrated menopause care experience — from assessment and physician consultation, to compounded prescription and home delivery, to ongoing education and research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Winona Bioidentical Hormone Replacement Therapy (HRT)
  • Winona Menopause Care Telehealth Service Physician-led telehealth service that empowers, educates, and treats women throughout perimenopause and menopause, bundling a free online medical intake / symptom quiz, free unlimited physician follow-ups via the patient portal, ongoing therapy adjustment, and prescribed compounded bioidentical HRT shipped directly to the patient's home. The service is available in 33 U.S. states and Puerto Rico and can be paused or canceled anytime.

Quantifiable outcome

  • 75% of women report six or more concurrent menopause symptoms
  • +7 more outcomes

Companies that use Winona

Customer profile

Segments4 records

Ideal customer profiles2 records

Winona technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Winona partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Winona competitors and assessment

Company assessment

Direct peers

  • Midi Health: Midi Health is a venture-backed telehealth clinic focused on perimenopause and menopause care for women 35+, offering clinician-prescribed HRT and lifestyle interventions. Direct overlap with Winona on target customer (midlife women), care model (telehealth + prescription), and treatment category (HRT).
  • Evernow: Evernow is a telehealth provider offering virtual menopause care with prescriptions for HRT and non-hormonal treatments delivered to patients' homes. Closely comparable to Winona in patient profile, telehealth-first delivery, and HRT-led treatment model.
  • Elektra Health: Elektra Health is a digital menopause care platform combining telehealth clinicians with education and community programming for women in midlife. Comparable to Winona on patient segment and virtual care delivery, with overlapping emphasis on education and community alongside clinical care.
  • Alloy Women's Health: Alloy is a telehealth platform serving women 40+ with menopause and perimenopause treatment including compounded bioidentical HRT. Direct peer to Winona in compounded HRT prescribing, cash-pay subscription model, and perimenopause/menopause positioning.
  • Gennev: Gennev is a women's health platform focused on menopause care, offering telehealth visits with menopause-certified providers and prescription treatments. Comparable to Winona on patient demographic (women in menopause), virtual care delivery, and treatment-led approach.
  • Bonafide Health: Bonafide is a women's health company offering non-prescription and clinician-recommended products for menopause symptoms, with a growing telehealth and prescription offering. Adjacent to Winona in menopause symptom treatment, with overlap in audience and DTC women's health positioning.

Broad incumbents

  • Hims & Hers Health: Hims & Hers is a large-scale telehealth and DTC wellness platform offering prescriptions across multiple categories including women's health and hormone-related treatments. Broader incumbent that competes for the same telehealth-HRT consumer wallet but operates across many conditions beyond menopause.
  • Ro (Roman): Ro is a multi-condition telehealth and pharmacy platform offering at-home diagnostics, prescriptions, and ongoing care, with categories overlapping women's health. Comparable as a broad incumbent in DTC telehealth but not specialized in menopause.

Emerging players

  • Maven Clinic: Maven Clinic is a virtual care platform focused on women's and family health, including fertility, pregnancy, postpartum, and increasingly perimenopause/menopause. Overlaps with Winona on women's virtual care audience and employer channel, but is broader across the life stages.
  • Tia: Tia operates hybrid in-person and virtual women's health clinics covering primary care, gynecology, and perimenopause/menopause care. Comparable to Winona on women-focused care and menopause, though Tia differentiates via physical clinics and a different cost structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Winona social profiles

Digital presence

Winona financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Winona leadership team

Management profile

Number of profiles

Profiles7 records

Winona funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Winona M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Winona

What does Winona do?

Winona is a direct-to-consumer telehealth company that prescribes and delivers personalized, compounded bioidentical hormone replacement therapy (HRT) for perimenopausal and menopausal women. Treatments include body cream, vaginal, oral, and patch formulations prescribed by board-certified physicians based on symptom severity rather than blood or saliva hormone testing, and shipped directly to patients' homes. The service bundles a free online medical intake, free unlimited physician follow-ups, and pause-or-cancel-anytime flexibility, available in 33 U.S. states and Puerto Rico.

Is Winona a public or private company?

Winona is a private company. It is classified as venture growth investor backed and is currently operating.

When was Winona founded?

Winona was founded in 2020. It employs 101 to 250 people.

Where is Winona based?

Winona is headquartered in Austin, United States, in the North America region.

How does Winona make money?

Three revenue lines are on record. Direct-to-Consumer Telehealth HRT Subscriptions are the primary driver. The others are out-of-Pocket and HSA/FSA Medication Sales and corporate Wellness Partnerships.

Who are Winona's main competitors?

Direct peers on record are Midi Health, Evernow, Elektra Health, Alloy Women's Health, Gennev and Bonafide Health. Broad incumbents are Hims & Hers Health and Ro (Roman). Emerging players are Maven Clinic and Tia.

Does Winona have an API?

No public API is recorded for Winona.

What industry is Winona in?

Winona's product category is Menopause Telehealth. Its primary akta.pro industry code is HLALAHAB, Contraception & Family Planning Telehealth (birth control, counseling, follow-up), with a secondary code of HLALACAI, Virtual PT/OT/MSK & Rehab Programs (Payer-Sponsored). Its NAICS code is 62161 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyWinona expands menopause care with supplement launchWinona has launched a new line of supplements aimed at supporting women through menopause, expanding its health offerings beyond hormone replacement therapy. The products address concerns such as sleep, digestive health, bone and muscle strength, and nutrition for women over 35. The company views menopause as a strategic opportunity to improve women's long-term healthspan and broader longevity outcomes.Longevity.TechnologyMenopause telehealth leader Winona launches menopause supplement lineWinona, a physician-led telehealth company specializing in menopause and perimenopause care, announced the launch of a branded line of four supplement formulations targeting women across the menopause transition. The product line includes a Pre + Pro Biotic Blend, Magnesium Blend, Women's Multivitamin, and Calcium with D3 + K2 and B12, designed to complement hormone replacement therapy or serve women who are not candidates for HRT. The company positions the supplements as supplemental tools to personalized medical care provided by its board-certified physicians, emphasizing clean, thoughtfully sourced ingredients free from common allergens.HIT ConsultantMenopause Telehealth Leader Winona Launches Physician-Formulated Supplement Line for Women 35+Winona, a physician-led menopause telehealth platform, has launched a proprietary line of science-backed supplements designed for women aged 35+, targeting midlife health priorities including bone density, sleep, gut health, and muscle recovery. The new nutraceutical suite is designed to complement their existing Hormone Replacement Therapy services or serve as a non-hormonal alternative for women not ready for HRT. Developed under Medical Director Dr. Cathleen Brown and Co-Founder Ashlie Beiter, the products are free from common allergens and feature evidence-based ingredients including probiotic blends, multi-form magnesium complexes, and calcium with vitamins D3 and K2.MorningstarMenopause Telehealth Leader Winona Launches Line of Supplements Specifically Formulated to Help Women Navigate the Menopause TransitionWinona, a menopause telehealth company, launched a branded supplement line for women navigating the menopause transition. The line includes a probiotic blend, magnesium, multivitamin, and calcium with D3, K2, and B12, designed to complement hormone therapy or support women who don't qualify. The products target common midlife concerns like digestion, sleep, and bone health.PR NewswireMenopause Telehealth Leader Winona Launches Line of Supplements Specifically Formulated to Help Women Navigate the Menopause TransitionWinona, a physician-led telehealth company, launched a branded supplement line for women navigating perimenopause and menopause. The line includes a magnesium blend, prebiotic blend, multivitamin, and calcium with D3, K2, and B12, formulated for women 35+.MedCity NewsMedCity FemFwd: Inside Winona’s New Women’s Health Research InitiativeMedCity FemFwd podcast featured Dr. Cathleen Brown, medical director at Winona, discussing the company's new Winona Research Initiative aimed at funding menopause and women's health research by supporting medical students, residents, and early career physicians with funding and mentorship to present their work at scientific meetings. Winona has also released a report showing women experience an average of nine or more menopause symptoms simultaneously and often suffer for one to three years before finding appropriate care. The initiative is funded from company profits and reflects a broader effort to address the historical gap in women's health research funding and medical education.Longevity.TechnologyWinona study finds 3 in 4 women battle 6 or more menopause symptoms simultaneouslyWinona released its State of Menopause 2026 research analyzing more than 100,000 de-identified patient intake assessments collected between May 2025 and February 2026. The analysis found that women seeking menopause care report an average of nine concurrent symptoms, with 75% reporting six or more symptoms at once and 77.5% living with symptoms for at least one year before finding care. The research also identified patient treatment preferences, with 67.5% preferring pills, 25.8% creams and 6.5% patches.PR NewswireWomen Seeking Menopause Care Report an Average of Nine Symptoms at Once, New Analysis of 100,000+ Patient Assessments FindsWinona, a physician-led telehealth company focused on menopause care, released its State of Menopause 2026 Report analyzing more than 100,000 patient intake assessments collected between May 2025 and February 2026. The analysis found that women seeking menopause care report an average of nine concurrent symptoms, with energy loss (79%), weight gain (75%), and fatigue (71%) being the most prevalent, while more than three in four women waited at least a year before seeking care. The report also found that cognitive and energy-related symptoms are central to the experience, with nearly 70% reporting brain fog and 57% falling into a combined brain fog and fatigue burden pattern.SecondopinionWhat's behind the rapid rise in virtual menopause careVirtual menopause care platforms are experiencing rapid growth as three converging forces reshape the market: the FDA's November 2025 removal of Black Box Warnings from six hormone replacement therapy products, declining stigma around menopause treatment, and the inherent suitability of virtual care for this condition. Midi Health, Alloy, Elektra Health, Stella, Winona, and other VC-backed entrants are scaling to serve a patient population historically underserved by a system where most OB/GYN residency programs lack menopause curricula. The shift reflects a clinical consensus reversal, backed by ACOG's 2024 reaffirmation of HRT as the most effective vasomotor symptom therapy for women under 60 within 10 years of menopause onset.MedCity NewsWinona Launches Menopause Research InitiativeWinona launched the Winona Research Initiative on Monday to fund menopause research, offering $3,000 stipends and support to scholars. The initiative follows a National Academies report showing only 8.8% of NIH grant spending from 2013-2023 focused on women's health. Applications are accepted on a rolling basis.